• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Gulden launches Practice Eyes to help enhance optometric skills

Article

The new Practice Eyes are ideal for teaching, refreshing, and practicing gonoiscopic examination skills such as examining and confirming normal angle structures, determining and measuring anterior chamber angle, and determining any developmental abnormalities.

 

Elkins Park, PA-Gulden Ophthalmics has introduced a new line of Premium Practice Eyes models. The Practice Eyes consist of an acrylic eye with either an 8 mm or 2 mm pupillary aperture and the entire internal structure of the retina. The Practice Eyes are filled with silicon oil that resembles the vitreous filled posterior chamber of the normal eye and provides incredible clarity of eye structures.

The Premium Practice Eyes are designed to also permit exceptional viewing of the anterior chamber angle of the eyes. All the essential structures of the angle are demonstrated and can be precisely seen. The models can demonstrate normal and diabetic retinas including diabetic retinopathy and retinal detachment.

The new Practice Eyes are ideal for teaching, refreshing, and practicing gonoiscopic examination skills such as examining and confirming normal angle structures, determining and measuring anterior chamber angle, and determining any developmental abnormalities.

Related Videos
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
Shelley Cutler, OD, FAAO, outlines her key takeaways from this year's IKA symposium
© 2024 MJH Life Sciences

All rights reserved.